Unknown PHASE2 INTERVENTIONAL 1-arm NCT02353429

Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets

Sponsor: Associazione Italiana per la Ricerca sul Cancro

Interventions Toremifene

Updated 5 times since 2017 Last updated: Jan 30, 2015 Started: Nov 30, 2012 Primary completion: Jun 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Desmoid Type-fibromatosis, this trial is ongoing. The trial is conducted by Associazione Italiana per la Ricerca sul Cancro and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Associazione Italiana per la Ricerca sul Cancro
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Data source: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy